Outcome	O
measurement	O

The	O
primary	O
endpoint	O
was	O
to	O
evaluate	O
the	O
efficacy	B-PrimaryOutcome
of	I-PrimaryOutcome
HCQ	I-PrimaryOutcome
with	I-PrimaryOutcome
respect	I-PrimaryOutcome
to	I-PrimaryOutcome
time	I-PrimaryOutcome
to	I-PrimaryOutcome
negative	I-PrimaryOutcome
rRT	I-PrimaryOutcome
-	I-PrimaryOutcome
PCR	I-PrimaryOutcome
assessments	I-PrimaryOutcome
from	B-TimeFrame
randomization	I-TimeFrame
up	I-TimeFrame
to	I-TimeFrame
14	I-TimeFrame
days	I-TimeFrame
.	O

The	O
secondary	O
endpoints	O
were	O
to	O
evaluate	O
the	O
proportion	B-SecondaryOutcome
of	I-SecondaryOutcome
negative	I-SecondaryOutcome
viral	I-SecondaryOutcome
rRT	I-SecondaryOutcome
-	I-SecondaryOutcome
PCR	I-SecondaryOutcome
on	B-TimeFrame
hospital	I-TimeFrame
day	I-TimeFrame
14	I-TimeFrame
,	O
the	O
resolution	B-SecondaryOutcome
of	I-SecondaryOutcome
clinical	I-SecondaryOutcome
symptoms	I-SecondaryOutcome
(	I-SecondaryOutcome
time	I-SecondaryOutcome
to	I-SecondaryOutcome
clinical	I-SecondaryOutcome
recovery	I-SecondaryOutcome
)	I-SecondaryOutcome
,	O
the	O
proportion	B-SecondaryOutcome
of	I-SecondaryOutcome
discharges	I-SecondaryOutcome
by	B-TimeFrame
day	I-TimeFrame
14	I-TimeFrame
,	O
and	O
the	O
mortality	B-SecondaryOutcome
rate	I-SecondaryOutcome
.	O

HCQ	B-OtherOutcome
safety	I-OtherOutcome
and	O
tolerability	B-OtherOutcome
were	O
also	O
evaluated	O
.	O

